ERBB2 and breast cancer: The presence and abundance of tumor-infiltrating lymphocytes (TILs) before NAC play crucial roles in the induction of therapeutic effects and favorable prognostic outcomes after chemotherapy for HER-2-positive and TN breast cancers [11].